These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6333507)

  • 21. Cerebral asymmetry in subtypes of schizophrenia.
    Tsai LY; Nasrallah HA; Jacoby CG
    J Clin Psychiatry; 1984 Oct; 45(10):423-5. PubMed ID: 6480566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive study of chronic schizophrenic patients. II: Biological, neuropsychological, and clinical correlates of CT abnormality.
    Pandurangi AK; Dewan MJ; Boucher M; Levy B; Ramachandran T; Bartell K; Bick PA; Phelps BH; Major L
    Acta Psychiatr Scand; 1986 Feb; 73(2):161-71. PubMed ID: 3705993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet monoamineoxidase activity in chronic schizophrenics.
    Gerbaldo H; Rozados RV; Filinger EJ
    Medicina (B Aires); 1985; 45(1):22-4. PubMed ID: 3880103
    [No Abstract]   [Full Text] [Related]  

  • 25. Negative symptoms and platelet monoamine oxidase activity in male schizophrenic patients.
    Lewine RJ; Meltzer HY
    Psychiatry Res; 1984 Jun; 12(2):99-109. PubMed ID: 6591224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
    Marcolin MA; Davis JM
    Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet MAO activity in schizophrenia and other psychiatric illnesses.
    Sullivan J; Stanfield CN; Dackis C
    Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral ventricular enlargement in chronic schizophrenia: consistencies and contradictions.
    Farmer A; Jackson R; McGuffin P; Storey P
    Br J Psychiatry; 1987 Mar; 150():324-30. PubMed ID: 3664100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poor outcome and low platelet MAO activity in chronic schizophrenia.
    Bierer L; Docherty JP; Young JG; Giller E; Cohen D
    Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?
    Del Vecchio M; Maj M; D'Ambrosio A; Kemali D
    Psychopharmacology (Berl); 1983; 79(2-3):177-9. PubMed ID: 6133302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT scans in sub-groups of chronic schizophrenics.
    Kling AS; Kurtz N; Tachiki K; Orzeck A
    J Psychiatr Res; 1982-1983; 17(4):375-84. PubMed ID: 7187780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet monoamine oxidase in families of chronic schizophrenics.
    Berrettini WH; Benfield TC; Schmidt AO; Ladman RK; Vogel WH
    Schizophr Bull; 1980; 6(2):235-7. PubMed ID: 7375856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age and duration of illness as predictors of ventricular brain ratio (VBR) size in chronic schizophrenic patients. A stepwise regression analysis study.
    Rossi A; Stratta P; Casacchia M; D'Albenzio L; Schiazza G; De Donatis M
    Acta Psychiatr Scand; 1987 Sep; 76(3):256-60. PubMed ID: 3673652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia.
    Pfefferbaum A; Zipursky RB; Lim KO; Zatz LM; Stahl SM; Jernigan TL
    Arch Gen Psychiatry; 1988 Jul; 45(7):633-40. PubMed ID: 3382323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.
    Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W
    Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative computed tomographic study in schizophrenia: cerebral density and ventricle measures.
    Rossi A; Stratta P; D'Albenzio L; Di Michele V; Serio A; Giordano L; Petruzzi C; Casacchia M
    Psychol Med; 1989 May; 19(2):337-42. PubMed ID: 2762438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
    Mann J; Thomas KM
    Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Decrease in the thrombocyte monoamine oxidase activity of schizophrenic patients].
    Kurilova II; Lideman RR
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(9):1351-4. PubMed ID: 706910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activities of types A and B MAO and catechol-o-methyltransferase in blood cells and skin fibroblasts of normal and chronic schizophrenic subjects.
    Groshong R; Baldessarini RJ; Gibson DA; Lipinski JF; Axelrod D; Pope A
    Arch Gen Psychiatry; 1978 Oct; 35(10):1198-1205. PubMed ID: 697538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione peroxidase and CT scan abnormalities in schizophrenia.
    Buckman TD; Kling AS; Eiduson S; Sutphin MS; Steinberg A
    Biol Psychiatry; 1987 Nov; 22(11):1349-56. PubMed ID: 3663787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.